Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H8QL
|
||||
Former ID |
DAP000722
|
||||
Drug Name |
Mazindol
|
||||
Synonyms |
Diestet; Dimagrir; Magrilon; Mazanor; Mazildene; Mazindole; Mazindolum; Sanjorex; Sanorex; Solucaps; Terenac; Teronac; Teronak; Mazindol Medix Brand; Mazindol Novartis Brand; Mazindol Searle Brand; Mazindol Wyeth Brand; Medix Brand of Mazindol; Novartis Brand of Mazindol; Searle Brand of Mazindol; Wyeth Brand of Mazindol; AN 448;AN448; S 42548; SAH 42548; AN-448; Mazanor (TN); Mazindolum [INN-Latin]; SA 42-548; SANOREX (TN); Sanorex (TN); Mazindol [USAN:BAN:INN]; Mazindol (JAN/USP/INN); (+-)-5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo(2,1-a)isoindol-5-ol; 5-(4-Chlorophenyl)-2,3-dihydro-5-hydroxy-5H-imidazo(2,1-a)isoindole; 5-(4-Chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol; 5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol; 5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo(2,1-a)isoindol-5-ol; 5-p-Chlorophenyl-2,3-dihydro-5H-imidazo(2,1-a)isoindol-5-ol; 5H-Imidazo(2,1-a)isoindol-5-ol, 5-(4-chlorophenyl)-2,3-dihydro
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Central Nervous System Stimulants
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H13ClN2O
|
||||
InChI |
InChI=1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2
|
||||
InChIKey |
ZPXSCAKFGYXMGA-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 22232-71-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
5663207, 7847433, 7979864, 8152518, 10514045, 14897762, 24896596, 29223131, 46509094, 48416196, 49978900, 51064091, 53789697, 57322096, 85174591, 92711740, 99431540, 103206445, 103856500, 103919017, 104305195, 125345244, 126630564, 126665962, 129938107, 131305866, 134338010, 134993905, 136949640, 137154621, 143038295, 152034992, 152258665, 160647502, 160830559, 160963924, 163094692, 163393871, 164228469, 164814279, 178101312, 178101499, 179116764, 186022457, 198993257, 204388874, 223664711, 224771980, 226415324, 241041015
|
||||
SuperDrug ATC ID |
A08AA05
|
||||
SuperDrug CAS ID |
cas=022232719
|
||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Modulator | [556264] | |
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
References | |||||
Ref 468026 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4797). | ||||
Ref 535114 | Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. Endocrine. 2000 Oct;13(2):193-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.